- Home
- EPWK vs FBIOP Comparison
EPWK vs FBIOP Comparison
Compare EPWK & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- FBIOP
- Stock Information
- Founded
- EPWK 2011
- FBIOP N/A
- Country
- EPWK China
- FBIOP United States
- Employees
- EPWK N/A
- FBIOP 101
- Industry
- EPWK
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- EPWK
- FBIOP Health Care
- Exchange
- EPWK Nasdaq
- FBIOP Nasdaq
- Market Cap
- EPWK N/A
- FBIOP N/A
- IPO Year
- EPWK 2025
- FBIOP N/A
- Fundamental
- Price
- EPWK $0.50
- FBIOP $9.02
- Analyst Decision
- EPWK
- FBIOP
- Analyst Count
- EPWK 0
- FBIOP 0
- Target Price
- EPWK N/A
- FBIOP N/A
- AVG Volume (30 Days)
- EPWK 3.1M
- FBIOP N/A
- Earning Date
- EPWK 05-27-2025
- FBIOP N/A
- Dividend Yield
- EPWK N/A
- FBIOP N/A
- EPS Growth
- EPWK N/A
- FBIOP N/A
- EPS
- EPWK N/A
- FBIOP N/A
- Revenue
- EPWK $20,164,008.00
- FBIOP N/A
- Revenue This Year
- EPWK N/A
- FBIOP N/A
- Revenue Next Year
- EPWK N/A
- FBIOP N/A
- P/E Ratio
- EPWK N/A
- FBIOP N/A
- Revenue Growth
- EPWK 10.25
- FBIOP N/A
- 52 Week Low
- EPWK $0.41
- FBIOP N/A
- 52 Week High
- EPWK $26.00
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- FBIOP 71.71
- Support Level
- EPWK N/A
- FBIOP $8.77
- Resistance Level
- EPWK N/A
- FBIOP $9.41
- Average True Range (ATR)
- EPWK 0.00
- FBIOP 0.53
- MACD
- EPWK 0.00
- FBIOP 0.10
- Stochastic Oscillator
- EPWK 0.00
- FBIOP 85.05
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.